News

The AMA has shifted from a behind-the-scenes lobbying strategy to more forceful public advocacy against President Trump's ...
A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.
An all-hands meeting at the CDC to discuss the attack on the agency on Friday was brief and chaotic, staffers say.
Insmed has received FDA clearance for the first treatment for a chronic lung disease, opening the biotech up to what could be ...
In at least six internal calls on Monday, CDC employees told leaders they worried that the agency wasn’t prepared for future ...
Ambient scribe company Abridge, partnering with Highmark Health, says it can give information on prior authorization during, ...
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Issues are piling up on Kennedy's watch, from responding to the CDC shooting to infighting over an FDA official.
So is a 500,000-square-foot lab building up the street, as well as one in Boston near Fenway Park. A sprawling complex on ...
A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...
NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...